EYE regeneration group in ESB Bordeaux, 4 – 8 of September, 2022
Our doctoral researcher Paula Puistola will give a presentation about our latest research results in 3D bioprinting of cornea on Monday, 5 September 2022, at 11:30 at 32nd annual conference of the European Society for Biomaterials (ESB) in Bordeaux, France. The title of her speech is “Novel multi-filament approach for 3D bioprinting of human stem cell –based corneal stroma mimicking structures.“
The public examination of the doctoral dissertation of MSc Meri Vattulainen, 1st of July, 2022
The doctoral dissertation of our doctoral candidate MSc Meri Vattulainen in the field of cell technology titled Human pluripotent stem cells for corneal applications will be publicly examined in the Faculty of Medicine and Health Technology of Tampere University at 12 o’clock on Friday 1st of June 2022 in auditorium F115 at Arvo building. The Opponent will be professor Majlinda Lako from Newcastle University, England. The Custos will be our PI professor Heli Skottman from the Faculty of Medicine and Health Technology of Tampere University. Learn more (in Finnish)
EYE regeneration group in TERMIS-EU Krakow, 28 – 30 of June, 2022
Our postdoctoral researcher Anni Mörö will give a podium presentation about our latest research results in 3D bioprinting of cornea on Wednesday, 29 June 2022, at 11:20 at TERMIS-EU in Krakow. The title of her speech is “Hyaluronic acid based next-generation bioink for 3d bioprinting of a human stem cell derived corneal stroma equivalent and a 3D cornea tissue model with innervation.“
EYE regeneration group in Nordic Congress of Ophthalmology, Reykjavik, Iceland, 9 – 11 of June 2022
Our PI professor Heli Skottman will give a presentation about our recent results regarding corneal cell differentiation from pluripotent stem cells. The title of her talk is “Human pluripotent stem cell based innovation for limbal and endothelial transplantations”.
EYE regeneration group in 6th European Aniridia Conference in Alicante, Spain, 3 – 5 of June, 2022
Our PI professor Heli Skottman will give a presentation about our recent results regarding aniridia modeling with patient specific induced pluripotent stem cells. The title of her talk is ”iPSC as a tool for understanding aniridia-associated keratopathy”.
EYE regeneration group granted Research-to-Business funding by Business Finland, 1st of January, 2022
The major funding is for exploring commercialization of the bioink developed in the Eye Regeneration group. The grant total is 550 000 €. The Reseach to Business funding from Business Finland is intended for public research organizations for projects in which research groups and researchers aim to develop their research into new business ideas and to commercialize their research results. Learn more